• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性盆腔浆液性肿瘤及相关病变的多面性:综述。

The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review.

机构信息

Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.

Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Adv Anat Pathol. 2022 May 1;29(3):154-167. doi: 10.1097/PAP.0000000000000334.

DOI:10.1097/PAP.0000000000000334
PMID:35180738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8989637/
Abstract

Ovarian serous tumors and related lesions are one of the most common conditions of the female genital tract. While ovarian high-grade serous carcinoma carries high mortality and adverse prognosis, most other serous lesions have better clinical behavior. In recent years, significant progress has been made in understanding the nature and histogenesis of these lesions that has contributed to better and more precise clinical management. Most of the high-grade serous carcinomas involve the ovaries and/or peritoneum, although in most cases, their origin seems to be in the fallopian tube. This view is supported by the recognition of precursor lesions in the fallopian tube, such as p53 signature and serous tubular in situ carcinoma. This paper presents salient morphologic, immunohistochemical, and molecular data related to serous tumors and related lesions of the female pelvis and discusses the histogenetic interrelationship among these lesions in light of current knowledge.

摘要

卵巢浆液性肿瘤及相关病变是女性生殖道最常见的疾病之一。卵巢高级别浆液性癌死亡率高,预后不良,而大多数其他浆液性病变具有较好的临床行为。近年来,人们对这些病变的性质和组织发生有了更深入的了解,这有助于更好、更精确地进行临床管理。大多数高级别浆液性癌累及卵巢和/或腹膜,尽管在大多数情况下,其起源似乎在输卵管。这一观点得到了在输卵管中发现的前驱病变的支持,如 p53 标志物和浆液性输卵管原位癌。本文介绍了与女性盆腔浆液性肿瘤及相关病变有关的显著形态学、免疫组织化学和分子数据,并根据目前的知识讨论了这些病变之间的组织发生关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cc7b0423d5dc/pap-29-154-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/c2800887bb27/pap-29-154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/6f06b02d68aa/pap-29-154-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/6735da798471/pap-29-154-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/255943d00897/pap-29-154-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/50e6d9b0a056/pap-29-154-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/b9bad3dd32d5/pap-29-154-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cf3c2fb90f3c/pap-29-154-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/4144a89618fd/pap-29-154-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/aebe23f9b288/pap-29-154-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/65cc93225881/pap-29-154-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cf5400f626d8/pap-29-154-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/0d6d006f2f13/pap-29-154-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/9963966b1ff8/pap-29-154-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/a5a7cbf9537b/pap-29-154-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/18793c1a06b3/pap-29-154-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/4caddd3553c8/pap-29-154-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/a2a4cbec4d3d/pap-29-154-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/5cb46758cfa1/pap-29-154-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/309a3cbf9c98/pap-29-154-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/48c167358ec1/pap-29-154-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/e440ef3100fe/pap-29-154-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/f708eefe2b32/pap-29-154-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/e1d272d65577/pap-29-154-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/82b9b7dc7c0c/pap-29-154-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/f44a16aca41f/pap-29-154-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/ec991c87b907/pap-29-154-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/f078e9a84d50/pap-29-154-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cc7b0423d5dc/pap-29-154-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/c2800887bb27/pap-29-154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/6f06b02d68aa/pap-29-154-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/6735da798471/pap-29-154-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/255943d00897/pap-29-154-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/50e6d9b0a056/pap-29-154-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/b9bad3dd32d5/pap-29-154-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cf3c2fb90f3c/pap-29-154-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/4144a89618fd/pap-29-154-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/aebe23f9b288/pap-29-154-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/65cc93225881/pap-29-154-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cf5400f626d8/pap-29-154-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/0d6d006f2f13/pap-29-154-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/9963966b1ff8/pap-29-154-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/a5a7cbf9537b/pap-29-154-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/18793c1a06b3/pap-29-154-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/4caddd3553c8/pap-29-154-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/a2a4cbec4d3d/pap-29-154-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/5cb46758cfa1/pap-29-154-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/309a3cbf9c98/pap-29-154-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/48c167358ec1/pap-29-154-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/e440ef3100fe/pap-29-154-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/f708eefe2b32/pap-29-154-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/e1d272d65577/pap-29-154-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/82b9b7dc7c0c/pap-29-154-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/f44a16aca41f/pap-29-154-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/ec991c87b907/pap-29-154-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/f078e9a84d50/pap-29-154-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c19a/8989637/cc7b0423d5dc/pap-29-154-g028.jpg

相似文献

1
The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review.女性盆腔浆液性肿瘤及相关病变的多面性:综述。
Adv Anat Pathol. 2022 May 1;29(3):154-167. doi: 10.1097/PAP.0000000000000334.
2
[Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].[卵巢浆液性肿瘤中输卵管上皮的形态学变化]
Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2012.07.001.
3
Are all pelvic (nonuterine) serous carcinomas of tubal origin?所有的盆腔(非子宫)浆液性癌都是输卵管来源的吗?
Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16.
4
[Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].[盆腔高级别浆液性癌中输卵管上皮的形态学特征]
Zhonghua Bing Li Xue Za Zhi. 2017 Aug 8;46(8):542-547. doi: 10.3760/cma.j.issn.0529-5807.2017.08.005.
5
Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?伴有卵巢低级别浆液性肿瘤的完全检查的输卵管中的黏膜增生:肿瘤前体病变还是良性黏膜的正常变体?
Int J Gynecol Pathol. 2018 May;37(3):262-274. doi: 10.1097/PGP.0000000000000410.
6
Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.乳头状输卵管上皮增生:卵巢非典型增生性(交界性)浆液性肿瘤、非浸润性种植和内输卵管上皮化生的可能前驱病变。
Am J Surg Pathol. 2011 Nov;35(11):1605-14. doi: 10.1097/PAS.0b013e318229449f.
7
Fallopian tube origin of supposed ovarian high-grade serous carcinomas.输卵管来源的疑似卵巢高级别浆液性癌。
Clinics (Sao Paulo). 2011;66(1):73-6. doi: 10.1590/s1807-59322011000100013.
8
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].[PAX8、PAX2、p53和RAS在卵巢及输卵管中的表达及其对卵巢高级别浆液性癌起源的意义]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008.
9
Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.浆液性癌输卵管前驱病变中的染色体不稳定性以及同步性卵巢和输卵管黏膜浆液性癌的频繁单克隆性。
Gynecol Oncol. 2008 Sep;110(3):408-17. doi: 10.1016/j.ygyno.2008.05.010. Epub 2008 Jul 1.
10
Taking the Tube: From Normal Fallopian Tube Epithelium to Ovarian High-grade Serous Carcinoma.输卵管:从正常输卵管上皮到卵巢高级别浆液性癌
Clin Obstet Gynecol. 2017 Dec;60(4):697-710. doi: 10.1097/GRF.0000000000000313.

引用本文的文献

1
Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor.表现为低级别浆液性癌和浆液性交界性肿瘤的高级别浆液性卵巢癌的分子分析
Curr Issues Mol Biol. 2024 Aug 25;46(9):9376-9385. doi: 10.3390/cimb46090555.
2
The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities.子宫内膜癌的DNA损伤反应(DDR)格局定义了不同的疾病亚型并揭示了治疗机会。
NAR Cancer. 2024 Apr 8;6(2):zcae015. doi: 10.1093/narcan/zcae015. eCollection 2024 Jun.
3
Massive serous cyst adenoma with ovarian abscess causing fatal septicaemia.
巨大浆液性囊腺瘤伴卵巢脓肿导致致命性败血症。
BMJ Case Rep. 2023 Nov 20;16(11):e255467. doi: 10.1136/bcr-2023-255467.